|
08-13-2010, 03:59 AM
|
|||
|
|||
Amgen: Vectibix fails in head and neck cancer test
Amgen Inc. said Wednesday its cancer drug Vectibix failed in a late-stage clinical trial, as it did not improve survival for patients with head and neck cancers compared to chemotherapy.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Amgen's Vectibix fails to meet endpoint in head and neck cancer trial | cancerfr | Head and Neck Cancer | 0 | 08-15-2010 04:48 PM |
| Amgen Announces Top-Line Results Of Phase 3 Head And Neck Cancer Trial | cancerfr | Head and Neck Cancer | 0 | 08-13-2010 03:59 AM |
| Amgen?s Vectibix Fails In Head-And-Neck Cancer | cancerfr | Head and Neck Cancer | 0 | 08-13-2010 03:59 AM |
| Amgen Head and Neck Cancer Study: A Disappointment | cancerfr | Head and Neck Cancer | 0 | 08-13-2010 03:59 AM |
| Amgen reports top-line results from Vectibix Phase 3 trial for head and neck cancer | cancerfr | Pancreatic Cancer | 0 | 08-13-2010 03:59 AM |
Linear Mode
